Brazil authorised the Butantan-DV single-dose dengue vaccine on 26 November for people aged 12 to 59. Health experts say a single dose could improve protection in remote and hard-to-reach areas such as the Amazon. The approval comes after Brazil's large dengue epidemic in 2024, when 6.4 million cases and 5,972 deaths were reported. Globally, more than 14 million cases were reported in 2024 and 12.6 million of those were in Latin America.
Late-stage trials in Brazil with 16,000 volunteers over nearly a decade showed 74.7% overall efficacy and 91.6% efficacy against severe dengue. Recent data indicates 100% efficacy against hospitalisations. Butantan said the vaccine will join the national immunisation programme in early 2026. More than 1 million doses are ready, and a partnership with WuXi Vaccines aims to produce 60 million doses over the next two years.
Difficult words
- authorised — give official permission or approval
- single-dose — vaccine given in one injection
- remote — far away from towns or cities
- epidemic — many people sick at the same time
- efficacy — how well a medicine or vaccine works
- severe — very bad or serious in effect
- immunisation — program to give vaccines to many people
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Do you think a single-dose vaccine is useful in remote places? Why?
- How would you feel if a vaccine had high protection against severe illness?
- Have you or someone you know had a vaccine that helped prevent a serious disease?
Related articles
Turning Water Hyacinth into Biodegradable Sanitary Pads
Researcher Pooja Singh and colleagues used invasive water hyacinth to make eco-friendly sanitary pads. Their project won an Elsevier award in Pune and aims to reduce water and plastic pollution while supporting women in local communities.
Dopamine helps lock in new skills during sleep
A study from the University of Michigan finds that dopamine neurons become active during NREM sleep soon after a person learns a movement. Their activity, together with sleep spindles, strengthens motor memories and improves skills after sleep.
New AI tools for tuberculosis shown at lung health conference
Researchers presented four new AI approaches for detecting and monitoring TB at the Union World Conference on Lung Health in Copenhagen (18–21 November). The tools include breath analysis, cough screening, vulnerability mapping and a chest X‑ray tool for children.
Engineered antibodies could block cytomegalovirus
A research team created changed antibodies that stop human cytomegalovirus from disabling immune responses. Lab tests show the antibodies reduce virus spread, but researchers say more testing is needed before they can be used in people.